Diabetic Macular Edema (DME) Recruiting Phase 2 / 3 Trials for Ranibizumab (DB01270)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01635790Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)Treatment